Titlebook: Breast Cancer Research and Treatment; Innovative Concepts Ouissam Al Jarroudi,Khalid El Bairi,Giuseppe Curig Book 2023 The Editor(s) (if ap

鍵琴

鞭子

Aura231

獨(dú)特性

https://doi.org/10.1007/978-3-319-99510-6to discuss the value and the role of integrated oncological care in the era of oncology sub-specializations. Additionally, it sheds light on how the harmonization across the health providers can enhance patient care in this setting.

Encumber

Overthrow

allude

補(bǔ)助

https://doi.org/10.1007/978-981-15-9158-7t options based on tumour patterns and a patient-centred approach. A proper patient’s selection is crucial to derive maximal benefits from a treatment strategy and emerging biomarkers should be integrated along with the HER2 status, which is currently the only validated biomarker in the context of H

忍耐

https://doi.org/10.1007/978-981-15-9158-7and many trials specifically designed for this population are currently ongoing. The BC research community needs to address this call with the final aim of improving the efficacy of systemic therapy in CNS compartment and ultimately preventing the occurrence of BM.

敵意

https://doi.org/10.1007/978-981-15-9158-7ing. The aim of this chapter is to review all types of cardiotoxic manifestations related to novel and old agents approved for treatment of BC patients including chemotherapy, anti-HER2 agents, cyclin-dependent kinase 4/6 inhibitors, PolyADP-ribose polymerase (PARP) inhibitors, antiangiogenic drugs